Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $37.1200 (-1.77%) ($37.1200 - $37.9200) on Mon. Oct. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.8% (three month average) | RSI | 44 | Latest Price | $37.1200(-1.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.1% a day on average for past five trading days. | Weekly Trend | HALO declines -3.3% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(49%) IWM(48%) IWC(45%) IWN(45%) | Factors Impacting HALO price | HALO will decline at least -0.9% in a week (0% probabilities). VIXM(-29%) VXX(-10%) UUP(-10%) GLD(-2%) TBT(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.9% (StdDev 1.8%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $30.25(-18.51%) | Resistance Level | $39.06 | 5 Day Moving Average | $37.35(-0.62%) | 10 Day Moving Average | $37.85(-1.93%) | 20 Day Moving Average | $39.06(-4.97%) | To recent high | -13.5% | To recent low | 1.6% | Market Cap | $5.073b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |